These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15342369)
1. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cheung PK; Woolcock B; Adomat H; Sutcliffe M; Bainbridge TC; Jones EC; Webber D; Kinahan T; Sadar M; Gleave ME; Vielkind J Cancer Res; 2004 Sep; 64(17):5929-33. PubMed ID: 15342369 [TBL] [Abstract][Full Text] [Related]
2. Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse. Noorali S; Kurita T; Woolcock B; de Algara TR; Lo M; Paralkar V; Hoodless P; Vielkind J Differentiation; 2007 Apr; 75(4):325-36. PubMed ID: 17286605 [TBL] [Abstract][Full Text] [Related]
3. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
4. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Kang JS; Calvo BF; Maygarden SJ; Caskey LS; Mohler JL; Ornstein DK Clin Cancer Res; 2002 Jan; 8(1):117-23. PubMed ID: 11801547 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401 [TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642 [TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Das S; Roth CP; Wasson LM; Vishwanatha JK Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896 [TBL] [Abstract][Full Text] [Related]
10. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma. Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298 [TBL] [Abstract][Full Text] [Related]
11. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15. Huang CY; Beer TM; Higano CS; True LD; Vessella R; Lange PH; Garzotto M; Nelson PS Clin Cancer Res; 2007 Oct; 13(19):5825-33. PubMed ID: 17908975 [TBL] [Abstract][Full Text] [Related]
12. Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. Diaz JI; Cazares LH; Corica A; John Semmes O Urol Oncol; 2004; 22(4):329-36. PubMed ID: 15283892 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377 [TBL] [Abstract][Full Text] [Related]
14. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach. Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042 [TBL] [Abstract][Full Text] [Related]
15. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens. Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of genomic aberrations associated with prostate cancer progression. Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia. Zhou T; Xu C; He M; Sun Y Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760 [TBL] [Abstract][Full Text] [Related]
19. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422 [TBL] [Abstract][Full Text] [Related]
20. Expression and role of Foxa proteins in prostate cancer. Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]